Amount of additional term payment.

No definition available.

Name:	drts_AdditionalTermPayment
Namespace Prefix:	drts_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of agreement payments.

+ References

No definition available.

+ Details

Name:	drts_AgreementPayments
Namespace Prefix:	drts_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

During the period of agreements term.

+ References

No definition available.

+ Details

Name:	drts_AgreementsTerms
Namespace Prefix:	drts_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of installments payments.

+ References

No definition available.

+ Details

Name:	drts_InstallmentsPayments
Namespace Prefix:	drts_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Represent the total value of liabilities assumed.

+ References

No definition available.

+ Details

Name:	drts_LiabilitiesAssumed
Namespace Prefix:	drts_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The maximum potential amount of payment based on a agreement.

+ References

No definition available.

+ Details

Name:	drts_PotentialPayment
Namespace Prefix:	drts_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The percentage at which royalty payments will be paid out on relative to the amount of grants received plus interest at LIBOR rate.

+ References

No definition available.

+ Details

Name:	drts_RoyaltyPaymentAsPercentageOfGrants
Namespace Prefix:	drts_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage at which royalty payments will be paid out on.

+ References

No definition available.

+ Details

Name:	drts_RoyaltyRate
Namespace Prefix:	drts_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represent the amount of upfront payment.

+ References

No definition available.

+ Details

Name:	drts_UpfrontPayment
Namespace Prefix:	drts_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Fair value portion of guarantee, including, but not limited to, financial standby letter of credit, fair value guarantee, guarantee of collection of scheduled contractual cash flows from financial assets, and contracts that contingently require the guarantor to make payments or perform services.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-10

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

+ Details

Name:	us-gaap_GuaranteesFairValueDisclosure
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount the entity has committed to make for future royalty guarantees.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 928
-SubTopic 440
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477866/928-440-50-1

+ Details

Name:	us-gaap_RoyaltyGuaranteesCommitmentsAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	dei_LegalEntityAxis=drts_IsraelInnovationAuthorityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=drts_AltheraMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_FutureSalesOfDevelopedProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_FutureGrossRevenueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_NetSalesOfAllCompanyProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=drts_RamotMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_NetSalesOfAllCompanyProductSoldByCompanyLicensesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_SalesOfAlphaRadiationProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=drts_BgnTechnologiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_SalesOfProductContainingIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_LicenseRevenueToJointlyDevelopedIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_LicenseRevenueRelatedToIntellectualPropertyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_RevenueGeneratedFromPatentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=drts_CambridgeUniversityHospitalsNhsTrustMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	drts_MethodOfPaymentRoyaltieAxis=drts_NetSalesSquamousCellCarcinomaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingent Liabilities (Details) - USD ($) $ in Thousands			6 Months Ended
	Dec. 01, 2020	Feb. 02, 2016	Jun. 30, 2026
Commitments and Contingent Liabilities [Line Items]
Guarantee amount (in Dollars)			$ 4,133
Aggregate amount (in Dollars)			$ 5,533
Royalty rate			7.00%
Royalty payment as a percentage of grants			100.00%
Agreement payments (in Dollars)			$ 3,000
Upfront payment (in Dollars)			500
Installments payments (in Dollars)			500
Additional term payment			$ 5,000
Agreements terms			20 years
Israel Innovation Authority [Member]
Commitments and Contingent Liabilities [Line Items]
Liabilities assumed (in Dollars)			$ 7,807
Althera [Member]
Commitments and Contingent Liabilities [Line Items]
Liabilities assumed (in Dollars)			$ 474
Potential payment (in Dollars)		$ 1,500
Future Sales of Developed Product [Member] \| Minimum [Member] \| Israel Innovation Authority [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate			3.00%
Future Sales of Developed Product [Member] \| Maximum [Member] \| Israel Innovation Authority [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate			100.00%
Future Gross Revenue [Member] \| Althera [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate		2.00%
Net Sales of All Company Product [Member] \| Ramot [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate			2.50%
Net Sales of All Company Product Sold By Company Licenses [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty payment as a percentage of grants			0.65%
Sales of Alpha Radiation Products [Member] \| BGN Technologies [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate			0.75%
Sales of Product Containing Intellectual Property [Member] \| BGN Technologies [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate			1.50%
License Revenue to Jointly Developed Intellectual Property [Member] \| BGN Technologies [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate			4.00%
License Revenue Related to Intellectual Property [Member] \| BGN Technologies [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate			8.00%
Revenue Generated from Patent [Member] \| Cambridge University Hospitals Nhs Trust [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate	5.00%
Net Sales Squamous Cell Carcinoma [Member] \| Cambridge University Hospitals Nhs Trust [Member]
Commitments and Contingent Liabilities [Line Items]
Royalty rate	2.00%